Cancer Genetics Inc (NASDAQ:CGIX)

During the Trading Day
11.05 +0.22 / +2.03%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.79 -0.265 / -2.40%
 
Volume: 174.00
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$106.4M

Company Description

Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays, and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Information

Cancer Genetics, Inc.
Meadows Office Complex
Rutherford New Jersey 07070
P:(201) 528-9200
Investor Relations:

Employees

Shareholders

Mutual fund holders8.02%
Other institutional5.47%
Individual stakeholders22.16%

Top Executives

Panna L. SharmaPresident, Chief Executive Officer & Director
Robert FannonVice President-Operations
Edward J. SitarChief Financial Officer, Secretary & Treasurer
Jane Houldsworth El NaggarVice President-Research & Development
Mandar KulkarniChief Technology Officer

To view my watchlist

Not a member yet?

Sign up now for a free account